JCM
DXCM icon

Jacobi Capital Management’s DexCom DXCM Stock Holding History

Jacobi Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-364
Closed -$50K – 644
2021
Q3 		$50K Buy
364
+16
+5% +$2.02K 0.01% 655
2021
Q2 		$37K Buy
348
+84
+32% +$8.07K ﹤0.01% 699
2021
Q1 		$24K Buy
264
+156
+144% +$14.6K ﹤0.01% 738
2020
Q4 		$10K Buy
108
+72
+200% +$6.43K ﹤0.01% 863
2020
Q3 		$4K Buy
36
+20
+125% +$2.09K ﹤0.01% 974
2020
Q2 		$2K Buy
+16
New +$1.43K ﹤0.01% 1040

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobi Capital Management's DXCM Position: Q4 2021 in Review

Jacobi Capital Management sold out of DexCom (DXCM) in Q4 2021, closing a stake of 364 shares — an estimated $50K sold.

Jacobi Capital Management first reported a position in DXCM in Q2 2020 and held it in 6 quarters. The position peaked at $50K in Q3 2021. 930 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Jacobi Capital Management reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 364 DexCom shares in Q4 2021, an estimated $50K.
  • Jacobi Capital Management first reported a position in DexCom in Q2 2020 and held it in 6 quarters.
  • Jacobi Capital Management's DexCom position peaked at $50K in Q3 2021.
  • 930 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.